High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis

Documents similaires

• Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
  par: Blackman, D, et autres
  Publié: (2004)
• Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
  par: Porto, I, et autres
  Publié: (2005)
• Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
  par: Nisha Ohri, MD, et autres
  Publié: (2016-01-01)
• Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
  par: Violeta Dinesch, et autres
  Publié: (2017-04-01)
• Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
  par: Negar Faramarzi, et autres
  Publié: (2015-10-01)